0001104659-20-106737.txt : 20201026 0001104659-20-106737.hdr.sgml : 20201026 20200921070104 ACCESSION NUMBER: 0001104659-20-106737 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20200921 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200921 DATE AS OF CHANGE: 20200921 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AdaptHealth Corp. CENTRAL INDEX KEY: 0001725255 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 823677704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38399 FILM NUMBER: 201185164 BUSINESS ADDRESS: STREET 1: 220 WEST GERMANTOWN PIKE STREET 2: SUITE 250 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: 610-630-6357 MAIL ADDRESS: STREET 1: 220 WEST GERMANTOWN PIKE STREET 2: SUITE 250 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 FORMER COMPANY: FORMER CONFORMED NAME: DFB Healthcare Acquisitions Corp. DATE OF NAME CHANGE: 20171213 8-K 1 tm2031210d1_8k.htm FORM 8-K
0001725255 false 0001725255 2020-09-21 2020-09-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

AdaptHealth Corp.

 

(Exact name of registrant as specified in its charter)

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): September 21, 2020

 

Delaware  001-38399  82-3677704
(State or other jurisdiction of
incorporation)		  (Commission File Number)  (IRS Employer Identification No.)

 

220 West Germantown Pike, Suite 250

Plymouth Meeting, PA

(address of principal executive offices)

 

19462

(zip code)

 

(610) 630-6357

(Registrant’s telephone number, including area code)

 

 

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  Trading Symbol(s)  Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per share  AHCO  The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On September 21, 2020, AdaptHealth Corp., a Delaware corporation (the “Company”), announced that Frank Mullen, age 50, was appointed as the Company’s Chief Accounting Officer (“CAO”) effective immediately.

 

There were no arrangements or understandings between Mr. Mullen and any other person pursuant to which Mr. Mullen was selected as an officer. Mr. Mullen has no family relationships subject to disclosure under Item 401(d) of Regulation S-K or any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

 

Mr. Mullen has served as the Senior Vice President and Controller of Ryder System, Inc., a leading global logistics and transportation company, since September 2017. Prior to joining Ryder System, Mr. Mullen was Chief Accounting Officer of Global Eagle Entertainment Inc. and served as Vice President and Controller at Pinnacle Foods Inc. Prior to his role at Pinnacle Foods, Mr. Mullen spent over 15 years with Aramark, where he held positions of increasing responsibility culminating in his role as Vice President and Assistant Controller. Mr. Mullen began his career in the audit and assurance practice of Arthur Andersen LLP. Mr. Mullen holds a bachelor’s degree in accounting from Villanova University and is a Certified Public Accountant.

 

On August 12, 2020, the Company entered into an employment agreement with Mr. Mullen (the “Employment Agreement”), that will govern the terms of his employment as the Company’s Chief Accounting Officer effective as of his start date on September 21, 2020. Pursuant to the terms of the Employment Agreement, Mr. Mullen is entitled to an annual base salary of $295,000 and is eligible for to earn annual bonuses based upon the achievement of performance targets established for the applicable year, with a target annual bonus equal to 40% of his base salary. Mr. Mullen is also entitled to a one-time relocation bonus of $70,000, which will be paid within one week of his commencement date and is subject to recoupment in the event that Mr. Mullen’s employment is terminated within one year of his commencement date. Pursuant to the Employment Agreement, Mr. Mullen will also receive an initial grant of restricted shares of the Company’s Class A Common Stock, par value $0.0001 per share (the “Common Stock”), equal to $300,000 divided by the volume-weighted average price of the Company’s Common Stock for the 20 days immediately prior to his commencement date, subject to vesting based on continued service over the four years following his commencement date. Commencing with the 2021 fiscal year, he will be eligible to receive annual grants of equity-based incentive compensation with a target grant value of $50,000 under the Company’s 2019 Stock Incentive Plan. Mr. Mullen will also be eligible to participate in the Company’s employee benefit programs offered to full-time employees.

 

Pursuant to the Employment Agreement, if Mr. Mullen’s employment is terminated by the Company without “cause” (as such term is defined in the Employment Agreement), subject to his execution of a separation agreement and release, Mr. Mullen will be entitled to continued payment of his base salary for a period of six months following such termination.

 

Mr. Mullen will be subject to non-competition and non-solicitation restrictions during the term of his employment and for one year thereafter and is also subject to an indefinite non-disparagement provision. Mr. Mullen is also subject to customary confidentiality and invention assignment covenants.

 

On September 21, 2020, the Company issued a press release announcing the appointment of Mr. Mullen as CAO, a copy of which is filed as Exhibit 99.1 hereto and incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d)Exhibits

 

99.1 Press Release, dated September 21, 2020
104

The cover page from this Current Report on Form 8-K, formatted in Inline XBRL

 

- 2 -

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

AdaptHealth Corp.     
     
By: /s/ Jason Clemens    
  Jason Clemens     
  Chief Financial Officer     
     
Dated: September 21, 2020     

 

- 3 -

 EX-99.1 2 tm2031210d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

 

FOR IMMMEDIATE RELEASE

 

ADAPTHEALTH CORP. APPOINTS FRANK J. MULLEN

AS CHIEF ACCOUNTING OFFICER

 

Plymouth Meeting, PA – September 21, 2020 – AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a leading provider of home medical equipment, supplies and related services in the United States, announced today the appointment of Frank J. Mullen as Chief Accounting Officer, a newly created position. Mr. Mullen will report to Jason Clemens, AdapthHealth’s Chief Financial Officer.

 

Mr. Mullen will manage AdaptHealth’s accounting functions, including financial reporting, controls and operations. Additionally, he will lead the development, implementation and management of enterprise-wide practices, systems and internal controls.

 

Mr. Mullen brings over 25 years of public company accounting and finance leadership to AdaptHealth. He joins the Company from Ryder System, a leading global logistics and transportation company, where he served as Vice President and Controller. Prior to joining Ryder System, Mr. Mullen was Chief Accounting Officer of Global Eagle Entertainment and served as Vice President and Controller at Pinnacle Foods Inc. He spent more than 15 years with Aramark where he held positions of increasing responsibility culminating in his role as Vice President and Assistant Controller. Mr. Mullen began his career in the audit and assurance practice of the Philadelphia office of Arthur Andersen LLP.

 

Mr. Mullen holds a bachelor’s degree in accounting from Villanova University and is a Certified Public Accountant.

 

“Frank is a seasoned financial executive with a breadth and depth of experience in managing growing customer-centric companies,” said Mr. Clemens. “I look forward to partnering with Frank as we continue to implement AdaptHealth’s organic and acquisition-driven growth initiatives.”

 

"I am very excited to join AdaptHealth at this important point in its growth,” said Mr. Mullen. “The team’s commitment to operational and patient care excellence has helped set AdaptHealth apart in the healthcare industry and I look forward to supporting our continued growth.”

 

“Frank brings valuable public company experience and a proven ability to effectively manage accounting organizations of size and scale,” said Luke McGee, CEO. “As AdaptHealth continues to evolve, we recognize the need for transformational talent. We believe that Frank’s appointment highlights our commitment to building efficiencies across every business function.”

 

 

 

 

 

About AdaptHealth Corp.

 

AdaptHealth Corp. is a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States. AdaptHealth provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home, adapt to life and thrive. Product and services offerings include (i) sleep therapy equipment, supplies and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea, (ii) home medical equipment (HME) to patients discharged from acute care and other facilities, (iii) oxygen and related chronic therapy services in the home, and (iv) other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy and nutritional supply needs. The company is proud to partner with an extensive and highly diversified network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. AdaptHealth services beneficiaries of Medicare, Medicaid and commercial insurance payors. AdaptHealth services over approximately 1.6 million patients annually in all 50 states through its network of 220 locations in 38 states. Learn more at www.adapthealth.com.

 

Forward-Looking Statements

 

This press release includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding projections, estimates and forecasts of revenue and other financial and performance metrics, projections of market opportunity and expectations, the Company’s acquisition pipeline and the impact of the recent coronavirus (COVID-19) pandemic and our response to it. These statements are based on various assumptions and on the current expectations of Company management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on, by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company.

 

- 2 -

 

 

 

 

These forward-looking statements are subject to a number of risks and uncertainties, including the outcome of judicial and administrative proceedings to which the Company may become a party or governmental investigations to which the Company may become subject that could interrupt or limit the Company’s operations, result in adverse judgments, settlements or fines and create negative publicity; changes in the Company’s clients’ preferences, prospects and the competitive conditions prevailing in the healthcare sector; and the impact of the recent coronavirus (COVID-19) pandemic and the Company’s response to it. A further description of such risks and uncertainties can be found in the Company’s filings with the Securities and Exchange Commission. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that the Company presently knows or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect the Company’s expectations, plans or forecasts of future events and views as of the date of this press release. The Company anticipates that subsequent events and developments will cause the Company’s assessments to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements.

 

Contacts

 

AdaptHealth Corp.

 

Brittany Lett

Vice President, Marketing

(909) 915-4983

blett@adapthealth.com

 

The Equity Group Inc.

 

Devin Sullivan

Senior Vice President

(212) 836-9608

dsullivan@equityny.com

 

Kalle Ahl, CFA

Vice President

(212) 836-9614

kahl@equityny.com

 

- 3 -

 

 EX-101.SCH 3 ahco-20200921.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ahco-20200921_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 ahco-20200921_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 tm2031210d1_ex99-1img001.jpg GRAPHIC begin 644 tm2031210d1_ex99-1img001.jpg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tm2031210d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001725255 2020-09-21 2020-09-21 iso4217:USD shares iso4217:USD shares 0001725255 false 8-K AdaptHealth Corp. 2020-09-21 DE 001-38399 82-3677704 220 West Germantown Pike Suite 250 Plymouth Meeting PA 19462 610 630-6357 false false false false Class A Common Stock, par value $0.0001 per share AHCO NASDAQ true false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Cover
Sep. 21, 2020
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 21, 2020
Entity File Number 001-38399
Entity Registrant Name AdaptHealth Corp.
Entity Central Index Key 0001725255
Entity Tax Identification Number 82-3677704
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 220 West Germantown Pike
Entity Address, Address Line Two Suite 250
Entity Address, City or Town Plymouth Meeting
Entity Address, State or Province PA
Entity Address, Postal Zip Code 19462
City Area Code 610
Local Phone Number 630-6357
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class A Common Stock, par value $0.0001 per share
Trading Symbol AHCO
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 1 95 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://adapthealth.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2031210d1_8k.htm ahco-20200921.xsd ahco-20200921_lab.xml ahco-20200921_pre.xml tm2031210d1_ex99-1.htm http://xbrl.sec.gov/dei/2020-01-31 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2031210d1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "tm2031210d1_8k.htm" ] }, "labelLink": { "local": [ "ahco-20200921_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "ahco-20200921_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "ahco-20200921.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ahco", "nsuri": "http://adapthealth.com/20200921", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "tm2031210d1_8k.htm", "contextRef": "From2020-09-21to2020-09-21", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://adapthealth.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "tm2031210d1_8k.htm", "contextRef": "From2020-09-21to2020-09-21", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-US": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-US": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://adapthealth.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" } }, "version": "2.1" } ZIP 14 0001104659-20-106737-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-20-106737-xbrl.zip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